The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kane Matthew R. since 2019.
This trader's CIK number is 1769887.
At the time of last reporting, Kane Matthew R. was the President and CEO of Precision Biosciences Inc. (stock ticker symbol DTIL).
Also see all insider trading activities at Precision Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | DTIL | 0 | $0 | 146,227 | $1,612,289 | 336,133 | $28,737 |
| 2019 | DTIL | 0 | $0 | 0 | $0 | 10,000 | $11,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-05-13 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-05-13 | DTIL | Sale | 9,675 | 8.96 | 86,688 |
| 2021-05-07 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-05-07 | DTIL | Sale | 9,742 | 8.57 | 83,488 |
| 2021-05-10 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-05-10 | DTIL | Sale | 9,746 | 8.25 | 80,404 |
| 2021-04-21 | DTIL | Option Ex | 13,422 | 1.18 | 15,837 |
| 2021-04-12 | DTIL | Sale | 9,741 | 8.67 | 84,454 |
| 2021-04-12 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-04-08 | DTIL | Sale | 9,736 | 9.00 | 87,624 |
| 2021-04-09 | DTIL | Sale | 9,737 | 8.87 | 86,367 |
| 2021-04-08 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-04-09 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-03-12 | DTIL | Sale | 9,712 | 11.36 | 110,328 |
| 2021-03-12 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-03-10 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-03-11 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-03-10 | DTIL | Sale | 9,710 | 11.79 | 114,480 |
| 2021-03-11 | DTIL | Sale | 9,711 | 11.38 | 110,511 |
| 2021-02-18 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-02-18 | DTIL | Sale | 9,705 | 12.23 | 118,692 |
| 2021-02-16 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-02-17 | DTIL | Sale | 9,705 | 12.28 | 119,177 |
| 2021-02-16 | DTIL | Sale | 9,697 | 13.30 | 128,970 |
| 2021-02-17 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-01-26 | DTIL | Option Ex | 21,515 | .04 | 860 |
| 2021-01-26 | DTIL | Sale | 9,697 | 13.37 | 129,648 |
| 2021-01-22 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-01-22 | DTIL | Sale | 10,218 | 13.53 | 138,249 |
| 2021-01-25 | DTIL | Option Ex | 21,514 | .04 | 860 |
| 2021-01-25 | DTIL | Sale | 9,695 | 13.74 | 133,209 |
| 2019-09-23 | DTIL | Option Ex | 10,000 | 1.18 | 11,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kane Matthew R. (President and CEO of Precision Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.